Terbinafine transungual solution

Drug Profile

Terbinafine transungual solution

Alternative Names: P-3058

Latest Information Update: 03 May 2016

Price : $50

At a glance

  • Originator Polichem
  • Class Antifungals; Naphthalenes; Small molecules
  • Mechanism of Action Cell membrane modulators; Squalene monooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Onychomycosis

Most Recent Events

  • 18 Feb 2016 Phase-III clinical trials in Onychomycosis (In adolescents, In children) in Belgium, Italy, Latvia & Spain (Topical)
  • 18 Feb 2016 Phase-III clinical trials in Onychomycosis (In adolescents, In the elderly, In adults) in Belgium, Bulgaria, Czech Republic, Germany, Greece, Latvia, Lithuania, Poland, Slovakia, Russia & Sweden (Topical)
  • 15 Jun 2015 Phase-III clinical trials in Onychomycosis (In adolescents, In adults, In the elderly) in Hungary (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top